Octopus Biosafety (STU:OCR) Total Liabilities: €1.15 Mil (As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
10 GF Score
Price €0.10
GF Value €0.04
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Total Liabilities?

Octopus Biosafety STU:OCR 10 Total Liabilities is €1.15 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 10/100 and a GF Value™ of €0.04. The stock has 2 warning signs investors should review.

Octopus Biosafety's Total Liabilities for the quarter that ended in Dec. 2024 was €1.15 Mil.

Octopus Biosafety's quarterly Total Liabilities declined from Dec. 2022 (€3.07 Mil) to Dec. 2023 (€0.77 Mil) but then increased from Dec. 2023 (€0.77 Mil) to Dec. 2024 (€1.15 Mil).

Octopus Biosafety's annual Total Liabilities declined from Dec. 2022 (€3.07 Mil) to Dec. 2023 (€0.77 Mil) but then increased from Dec. 2023 (€0.77 Mil) to Dec. 2024 (€1.15 Mil).

Octopus Biosafety Total Liabilities Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Total Liabilities Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 2.33 3.07 0.77 1.15

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 2.33 3.07 0.77 1.15
STU:OCR
10GF Score
Octopus Biosafety STU:OCR
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Octopus Biosafety's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.985+(0.16+2.7755575615629E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.15

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=0.489--0.656
=1.15

Octopus Biosafety's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.985+(0.16+2.7755575615629E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.15

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=0.489--0.656
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.15 Mil mean?
Octopus Biosafety (STU:OCR) has a Total Liabilities of €1.15 Mil as of Dec. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Octopus Biosafety and its competitors.
Is Octopus Biosafety's Total Liabilities too high?
Octopus Biosafety's current Total Liabilities is €1.15 Mil. Overall, Octopus Biosafety has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Total Liabilities compare to SNDK and DELL?
Octopus Biosafety's Total Liabilities of €1.15 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Hardware company?
A good Total Liabilities depends on the Hardware industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Octopus Biosafety and its competitors. Octopus Biosafety's current Total Liabilities is €1.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Total Liabilities of €1.15 Mil. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 150% above its estimated fair value. The current Total Liabilities is €1.15 Mil. Octopus Biosafety's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Total Liabilities is €1.15 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 150% above its estimated GF Value™ of €0.04.

Key valuation signals for STU:OCR:

  • Total Liabilities: €1.15 Mil
  • GF Value™: €0.04 vs. price of €0.10 (150% above fair value)
  • GF Score™: 10/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
10GF Score

Get the complete analysis for STU:OCR

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.04
GF Value